XBI vs. SMMT
Compare and contrast key facts about SPDR S&P Biotech ETF (XBI) and Summit Therapeutics Inc. (SMMT).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: XBI or SMMT.
Correlation
The correlation between XBI and SMMT is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
XBI vs. SMMT - Performance Comparison
Key characteristics
XBI:
0.41
SMMT:
2.14
XBI:
0.74
SMMT:
5.44
XBI:
1.09
SMMT:
1.72
XBI:
0.20
SMMT:
7.48
XBI:
1.29
SMMT:
25.41
XBI:
8.18%
SMMT:
25.07%
XBI:
25.90%
SMMT:
298.18%
XBI:
-63.89%
SMMT:
-95.75%
XBI:
-47.44%
SMMT:
-44.03%
Returns By Period
In the year-to-date period, XBI achieves a 2.37% return, which is significantly lower than SMMT's 584.67% return.
XBI
2.37%
-3.20%
-1.05%
4.32%
-1.28%
4.32%
SMMT
584.67%
-2.99%
125.35%
654.01%
65.57%
N/A
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
XBI vs. SMMT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Biotech ETF (XBI) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
XBI vs. SMMT - Dividend Comparison
XBI's dividend yield for the trailing twelve months is around 0.14%, while SMMT has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
XBI SPDR S&P Biotech ETF | 0.14% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% | 0.17% |
SMMT Summit Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
XBI vs. SMMT - Drawdown Comparison
The maximum XBI drawdown since its inception was -63.89%, smaller than the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for XBI and SMMT. For additional features, visit the drawdowns tool.
Volatility
XBI vs. SMMT - Volatility Comparison
The current volatility for SPDR S&P Biotech ETF (XBI) is 7.92%, while Summit Therapeutics Inc. (SMMT) has a volatility of 17.79%. This indicates that XBI experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.